Comparison of NCCLS and 3-(4,5-dimethyl-2-Thiazyl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT) methods of in vitro susceptibility testing of filamentous fungi and development of a new simplified method.
about
Fusarium infections in immunocompromised patientsThe secreted antifungal protein thionin 2.4 in Arabidopsis thaliana suppresses the toxicity of a fungal fruit body lectin from Fusarium graminearumColorimetric assay for antifungal susceptibility testing of Aspergillus species.Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis [2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antAntifungal susceptibility testing: practical aspects and current challenges.Sulfur inhibits the growth of androgen-independent prostate cancer in vivo.Antifungal activity of phlorotannins against dermatophytes and yeasts: approaches to the mechanism of action and influence on Candida albicans virulence factor.Development and antimicrobial susceptibility studies of in vitro monomicrobial and polymicrobial biofilm models with Aspergillus fumigatus and Pseudomonas aeruginosa.Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanideIdentification of limiting factors for the optimum growth of fusarium oxysporum in liquid medium.Inorganic polyphosphate elicits pro-inflammatory responses through activation of the mammalian target of rapamycin complexes 1 and 2 in vascular endothelial cells.In Vitro Antifungal Activity and Mode of Action of 2',4'-Dihydroxychalcone against Aspergillus fumigatus.In vitro interactions between tacrolimus and azoles against Candida albicans determined by different methodsFusarium keratitis: genotyping, in vitro susceptibility and clinical outcomes.Evaluation of a scanner-assisted colorimetric MIC method for susceptibility testing of gram-negative fermentative bacteriaIn vitro activities of 10 antifungal drugs against 508 dermatophyte strainsComparison of the Etest and the sensititre colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus species.In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolatesComparison of fractional inhibitory concentration index with response surface modeling for characterization of in vitro interaction of antifungals against itraconazole-susceptible and -resistant Aspergillus fumigatus isolatesIn vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates.Voriconazole inhibits fungal growth without impairing antigen presentation or T-cell activation.Use of turbidimetric growth curves for early determination of antifungal drug resistance of filamentous fungi.Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solaniIn vitro interactions between amphotericin B, itraconazole, and flucytosine against 21 clinical Aspergillus isolates determined by two drug interaction models.Nicotinamide mononucleotide and related metabolites induce disease resistance against fungal phytopathogens in Arabidopsis and barley.Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis.In vitro susceptibility of Pythium insidiosum to macrolides and tetracycline antibiotics.
P2860
Q24685627-96E2475A-7BE0-46D3-87A1-F4725BD241F8Q31129863-F41B46CB-A315-4218-BEFF-7E369EF7740CQ33973504-26314457-E4EA-4ADD-AF6C-5BB4E8116BA8Q33974186-EAEA4A54-2C45-4CD9-8BF3-51AB83DE5001Q33975757-4D6ADA29-4E0F-432A-A17D-3120946E7F33Q34583885-751DD5D7-A729-41D0-8F5E-97CEB04503BDQ34951352-258950C2-0520-44BF-A2D6-A15A0AB3F632Q35109394-B44CBD72-3297-4D14-AD9A-DB428B83D9A7Q35194598-B20B4386-9750-4B3D-9B18-B20794326C65Q35245129-BCDA011D-043A-4CFC-9894-4F729E90B9DBQ35582599-6D8903FD-FBFE-4E86-AB30-FC54C28C5FD9Q35697196-9A0BBE76-70E3-445D-AE31-F87AE229A494Q36425093-93BE12EC-1C13-479D-9A1B-08BDC671C27DQ36756216-F601A70C-734F-4847-B64F-C8B82E0C03CDQ37318769-4A2C3754-4EB1-4B59-8070-0E5B36E1892AQ39478246-8D1784AA-E843-4EB4-8EEE-CC482FFEB56BQ39628247-089050F6-D6C6-4683-A37F-D8FFC08EE03CQ39650951-A1DE118B-C56B-4D7F-B7C7-16DE3AE972F3Q39653016-1ED406C6-3CB2-420F-9193-25AA70F40B4CQ39730865-9C5FA330-4680-4919-9625-FD59B91FCB73Q39755498-4EF8D430-2773-47B4-8653-065FBDDE7B38Q40133093-459C0FE7-E596-41B7-A0C9-5F7D6B2A1D71Q40667778-33275F1E-3201-40D3-8810-E336CCC60552Q40882541-2B16F79E-E79B-455A-B722-1AD41CCD12F1Q41123479-95E623B0-DAAB-48C7-9595-235290DBBEAFQ42286250-4C9F8DEA-1AE6-4A33-972B-E5B5025D59D7Q42772534-9D942F2C-62DC-4AEB-8600-EF43EA2A0BD6
P2860
Comparison of NCCLS and 3-(4,5-dimethyl-2-Thiazyl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT) methods of in vitro susceptibility testing of filamentous fungi and development of a new simplified method.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Comparison of NCCLS and 3-(4,5 ...... nt of a new simplified method.
@ast
Comparison of NCCLS and 3-(4,5 ...... nt of a new simplified method.
@en
type
label
Comparison of NCCLS and 3-(4,5 ...... nt of a new simplified method.
@ast
Comparison of NCCLS and 3-(4,5 ...... nt of a new simplified method.
@en
prefLabel
Comparison of NCCLS and 3-(4,5 ...... nt of a new simplified method.
@ast
Comparison of NCCLS and 3-(4,5 ...... nt of a new simplified method.
@en
P2093
P2860
P1476
Comparison of NCCLS and 3-(4,5 ...... ent of a new simplified method
@en
P2093
J Meletiadis
J P Donnelly
J W Mouton
P2860
P304
P407
P577
2000-08-01T00:00:00Z